The pharmaceutical company AstraZeneca has announced that it has resumed its coronavirus vaccine trial in the UK after suspending it six days ago over potential safety...Weekly Roundup
It's dog eat dog in the world of COVID-19 vaccines. Reuters Health reports that that's the fear of global health agencies planning a scheme to bulk-buy and equitably...
July 22nd, 2020The candidate coronavirus vaccine AZD1222, being developed by University of Oxford and AstraZeneca, generated an immune response in a study of roughly 1,000...
Volunteers who received Moderna's COVID-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health...
May 20th, 2020
It’s not an Aids vaccine but it may be the closest thing to one so far. A long-acting antiretroviral drug given as an injection every two months powerfully protected...
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a...International
Two of the world’s largest vaccine firms have teamed up to develop a coronavirus treatment that can be supplied to billions of people around the world. The Daily...Weekly Roundup
The World Health Organisation (WHO) has just quality assured a third pneumococcal conjugate vaccine (PCV), manufactured by the Serum Institute of India, that protects...South Africa
State-backed vaccine developer Biovac has secured the lion’s share of the government’s new R11.4bn contract to supply childhood vaccines, ending months of...HIV/AIDS
In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organisation funded primarily by Unitaid to...
